Design
Review
Authors
Loading...
Does not yet change hypertrophy management; leaves open RAS mediation as target for prospective trials.
Key points are not available for this paper at this time.
Paul et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: